Abstract:The protein WWOX was reported to be involved in cancer progression via interaction with mTOR and DNA repair pathway. We previously reported noteworthy association of some single nucleotide polymorphisms (SNPs) in mTOR and DNA repair pathways with gastric cancer (GCa) patients' survival. We hypothesized that genetic variants in WWOX gene could predict the survival of GCa patients. By extracting WWOX genetic variants from our ongoing genome-wide association study including 796 GCa patients from an Eastern Chinese population, we identified 51 out of 1913 SNPs to be significantly associated with survival of GCa patients, which passed the false positive probability tests. In particular, the intronic variant rs9922483, a G>T change, was associated with 21% increased death risk for GCa patients (HR = 1.21, 95% CI = 1.04-1.42, P = .015). This locus was predicted to be involved in potential enhancer by bioinformatics analysis. Genotype-phenotype correlation analysis revealed decreased expression of WWOX by rs9922483 G>T change. Mechanistically, rs9922483 locus may exhibits long-range interaction with WWOX promoter, and the G>T change inhibited the transcriptional activity driven by WWOX promoter in luciferase reporter system. Especially, the G>T change had an allele-specific negative effect on NR3C1 binding, and NR3C1 promoted the expression of WWOX in GCa cells. Further functional analysis indicated an increase in proliferation, migration and invasion of GCa cells by knockdown of WWOX. In conclusion, WWOX genetic variants may modulate survival of Chinese GCa patients by exerting remote regulatory effect on WWOX expression. Our results highlight the cis-regulatory effect of genetic variants on genes and survival modulation for GCa patients.

Update of the WWOX tumor suppressor gene

Common Chromosomal Fragile Site Gene WWOX in Metabolic Disorders and Tumors.

Ectopic WWOX Expression Inhibits Growth of 5637 Bladder Cancer Cell in Vitro and in Vivo

Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma.

Tumor suppressor WWOX moderates the mitochondrial respiratory complex

WWOX, Large Common Fragile Site Genes, and Cancer

Genetic and epigenetic alterations of WWOX in the development of gastric cardia adenocarcinoma.

Decreased Expression of WWOX in the Development of Esophageal Squamous Cell Carcinoma

Aberrant Expression of WWOX Protein in Epithelial Ovarian Cancer

A functional copy number variation in the WWOX gene is associated with lung cancer risk in Chinese.

Loss of WWOX expression in human extrahepatic cholangiocarcinoma

Roles of the WWOX in pathogenesis and endocrine therapy of breast cancer.

Aberrant Expression Of Wwox Protein In Epithelial Ovarian Cancer: A Clinicopathologic And Immunohistochemical Study

Expression of WWOX in tissues of breast cancer and its association with ER and menopausal status

Expression of WWOX Protein in Non-Small Cell Lung Cancer and Its Significance

Germline Mutation and Aberrant Transcripts of WWOX in a Syndrome with Multiple Primary Tumors

WWOX-mediated Apoptosis in A549 Cells Mainly Involves the Mitochondrial Pathway.

Expression of WWOX in Hepatocellular Carcinoma and Resection Margin

The Polymorphisms And Haplotypes Of Wwox Gene Are Associated With The Risk Of Lung Cancer In Southern And Eastern Chinese Populations

Remote Modulation of WWOX by an Intronic Variant Associated with Survival of Chinese Gastric Cancer Patients.

Antineoplastic Nature of WWOX in Glioblastoma Is Mainly a Consequence of Reduced Cell Viability and Invasion